Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 18, Issue 8, 2011, Pages 2395-2403

  Chang, Yu Jia ^a,b,c   Tai, Cheng Jeng ^c   Kuo, Li Jen ^a,b   Wei, Po Li ^a,b,c   Liang, Hung Hua ^a,b   Liu, Tsan Zon ^b   Wang, Weu ^a,b   Tai, Chen Jei ^b,e   Ho, Yuan Soon ^a,c   Wu, Chih Hsiung ^a,b,d   Huang, Ming Te ^a,b,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; CASPASE 3; CASPASE 8; CASPASE 9; CURCUMIN; GLUCOSE REGULATED PROTEIN 78; MESSENGER RNA; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; ENZYME REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL PROLIFERATION; CURCUMIN; FLOW CYTOMETRY; HEAT-SHOCK PROTEINS; HUMANS; IN SITU NICK-END LABELING; LIVER NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 80051547555     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1597-3     Document Type: Article

References (36)

1. DM Parkin 2001 Global cancer statistics in the year 2000 Lancet Oncol. 2 533 543 11905707 10.1016/S1470-2045(01)00486-7 1:STN:280:DC%2BD387ntlCrtw%3D%3D (Pubitemid 33586866)
2. R Cabrera DR Nelson 2010 Review article: the management of hepatocellular carcinoma Aliment Pharmacol Ther. 31 461 476 19925500 10.1111/j.1365-2036.2009. 04200.x 1:CAS:528:DC%2BC3cXitFKgsrw%3D
3. DM Nagorney JA van Heerden DM Ilstrup MA Adson 1989 Primary hepatic malignancy: surgical management and determinants of survival Surgery 106 740 748 2799650 1:STN:280:DyaK3c%2FhvF2ksQ%3D%3D (discussion 748-9)
4. Primary liver cancer in Japan 1990 Clinicopathologic features and results of surgical treatment Liver Cancer Study Group of Japan Ann Surg 211 277 287
5. KJ Paquet P Koussouris MA Mercado JF Kalk D Müting W Rambach 1991 Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study Br J Surg. 78 459 462 1851652 10.1002/bjs.1800780423 1:STN:280:DyaK3M3jsFSiug%3D%3D
6. A Sugioka T Tsuzuki T Kanai 1993 Postresection prognosis of patients with hepatocellular carcinoma Surgery. 113 612 618 8389492 1:STN:280: DyaK3s3otF2gtA%3D%3D (Pubitemid 23176302)
7. CC Huang MC Wu GW Xu DZ Li H Cheng ZX Tu, et al. 1992 Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma J Natl Cancer Inst. 84 262 264 1346405 10.1093/jnci/84.4.262 1:STN:280:DyaK387jtVaktg%3D%3D
8. L Liu Y Cao C Chen X Zhang A McNabola D Wilkie, et al. 2006 Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5 Cancer Res. 66 11851 11858 17178882 10.1158/0008-5472.CAN-06-1377 1:CAS:528:DC%2BD28Xhtlagu73F (Pubitemid 46094197)
9. JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc, et al. 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med. 359 378 390 18650514 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D
10. AL Cheng YK Kang Z Chen J Tsao S Qin JS Kim, et al. 2009 Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol. 10 25 34 19095497 10.1016/S1470-2045(08) 70285-7 1:CAS:528:DC%2BD1cXhsFChtbnM
11. L Rimassa A Santoro 2009 Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial Expert Rev Anticancer Ther. 9 739 745 19496710 10.1586/era.09.41 1:CAS:528:DC%2BD1MXmvFaguro%3D
12. T Zhang X Ding D Wei P Cheng X Su H Liu, et al. 2010 Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials Anticancer Drugs. 21 326 332 20016366 10.1097/CAD. 0b013e3283350e26 1:CAS:528:DC%2BC3cXhsVWitbY%3D
13. A Vitale ML Volk D Pastorelli S Lonardi F Farinati P Burra, et al. 2010 Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety Hepatology. 51 165 173 19877181 1:CAS:528:DC%2BC3cXhsVCqur4%3D
14. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 1998;28:751-5.
15. C Hsu YC Shen CC Cheng FC Hu AL Cheng 2010 Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial design Contemp Clin Trials. 31 55 61 19737631 10.1016/j.cct.2009.08.002
16. JF Chiou CJ Tai MT Huang PL Wei YH Wang J An, et al. 2010 Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma Ann Surg Oncol. 17 603 612 19830497 10.1245/s10434-009-0718-8
17. SO Lim SG Park JH Yoo YM Park HJ Kim KT Jang, et al. 2005 Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules World J Gastroenterol. 11 2072 2079 15810071 1:CAS:528:DC%2BD2MXktlWrsb0%3D (Pubitemid 40542649)
18. JM Luk CT Lam AF Siu BY Lam IO Ng MY Hu, et al. 2006 Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values Proteomics. 6 1049 1057 16400691 10.1002/pmic.200500306 1:CAS:528: DC%2BD28XhvFWrsrY%3D (Pubitemid 43260229)
19. M Shuda N Kondoh N Imazeki K Tanaka T Okada K Mori, et al. 2003 Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis J Hepatol. 38 605 614 12713871 10.1016/S0168-8278(03)00029-1 1:CAS:528: DC%2BD3sXjtFert7c%3D (Pubitemid 36560645)
20. P Anand C Sundaram S Jhurani AB Kunnumakkara BB Aggarwal 2008 Curcumin and cancer: an "old-age" disease with an "age-old" solution Cancer Lett. 267 133 164 18462866 10.1016/j.canlet.2008.03.025 1:CAS:528:DC%2BD1cXotlCgtbs%3D
21. CH Hsu AL Cheng 2007 Clinical studies with curcumin Adv Exp Med Biol. 595 471 480 17569225 10.1007/978-0-387-46401-5-21
22. S Singh A Khar 2006 Biological effects of curcumin and its role in cancer chemoprevention and therapy Anticancer Agents Med Chem. 6 259 270 16712454 10.2174/187152006776930918 1:CAS:528:DC%2BD28XkvFKkurg%3D (Pubitemid 43796643)
23. KM Dhandapani VB Mahesh DW Brann 2007 Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors J Neurochem. 102 522 538 17596214 10.1111/j.1471-4159.2007.04633.x 1:CAS:528:DC%2BD2sXot1Wgtrg%3D (Pubitemid 47000605)
24. AB Kunnumakkara P Anand BB Aggarwal 2008 Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins Cancer Lett. 269 199 225 18479807 10.1016/j.canlet.2008.03.009 1:CAS:528:DC%2BD1cXhtFWlsrjM
25. BB Aggarwal S Shishodia 2006 Molecular targets of dietary agents for prevention and therapy of cancer Biochem Pharmacol. 71 1397 1421 16563357 10.1016/j.bcp.2006.02.009 1:CAS:528:DC%2BD28Xjs1Gls74%3D
26. HO Pae SO Jeong GS Jeong KM Kim HS Kim SA Kim, et al. 2007 Curcumin induces pro-apoptotic endoplasmic reticulum stress in human leukemia HL-60 cells Biochem Biophys Res Commun. 353 1040 1045 17198682 10.1016/j.bbrc.2006.12.133 1:CAS:528:DC%2BD2sXmtVamuw%3D%3D (Pubitemid 46080402)
27. YJ Chang CC Chiu CH Wu J An CC Wu TZ Liu, et al. 2010 Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma Ann Surg Oncol. 17 1703 1709 20087778 10.1245/s10434-010-0912-8
28. SK Wang PH Liang RD Astronomo TL Hsu SL Hsieh DR Burton, et al. 2008 Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN Proc Natl Acad Sci USA. 105 3690 3695 18310320 10.1073/pnas.0712326105 1:CAS:528:DC%2BD1cXjs1Oit7s%3D (Pubitemid 351723459)
29. S Sowinski C Jolly O Berninghausen MA Purbhoo A Chauveau K Köhler, et al. 2008 Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission Nat Cell Biol. 10 211 219 18193035 10.1038/ncb1682 1:CAS:528:DC%2BD1cXhs1Kiuro%3D (Pubitemid 351194051)
30. MT Huang PL Wei JJ Liu DZ Liu H Huey-Chun J An, et al. 2010 Knockdown of thrombomodulin enhances HCC cell migration through increase of ZEB1 and decrease of E-cadherin gene expression Ann Surg Oncol. 17 3379 3385 20625840 10.1245/s10434-010-1163-4
31. BB Aggarwal B Sung 2009 Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets Trends Pharmacol Sci. 30 85 94 19110321 10.1016/j.tips.2008.11.002 1:CAS:528:DC%2BD1MXhs1eisbw%3D
32. QS Tong LD Zheng P Lu FC Jiang FM Chen FQ Zeng, et al. 2006 Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells Anticancer Drugs. 17 279 287 16520656 10.1097/00001813-200603000-00006 1:CAS:528:DC%2BD28XitVGntbw%3D
33. L Moragoda R Jaszewski AP Majumdar 2001 Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells Anticancer Res. 21 873 878 11396178 1:CAS:528:DC%2BD3MXksVOjsLY%3D (Pubitemid 32494183)
34. R Rashmi S Kumar D Karunagaran 2004 Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis Carcinogenesis. 25 179 187 14604899 10.1093/carcin/bgh001 1:CAS:528:DC%2BD2cXhtVKrur8%3D (Pubitemid 38239801)
35. S Nagata 2000 Apoptotic DNA fragmentation Exp Cell Res. 256 12 18 10739646 10.1006/excr.2000.4834 1:CAS:528:DC%2BD3cXitVajs7c%3D (Pubitemid 30211161)
36. M Kajstura HD Halicka J Pryjma Z Darzynkiewicz 2007 Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete "sub-G1" peaks on DNA content histograms Cytometry A. 71 125 131 17252584 (Pubitemid 46355337)